» Articles » PMID: 26557673

Ocular Surface and Tear Film Changes in Older Women Working with Computers

Overview
Journal Biomed Res Int
Publisher Wiley
Date 2015 Nov 12
PMID 26557673
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

The aim of this work is to investigate changes in the ocular surface (OS) and tear film (TF) by means of questionnaire-based subjective symptoms, TF break-up time, Schirmer test, and TF analysis in women working with computers and to analyze the effects of the oral supplementation with antioxidants/omega 3 fatty acids (A/ω3) in the OS outcomes. Women aged 40-65 years (n = 148) were recruited at the Administrative Offices of Valencia (Spain) and distributed into two age groups, 40-52 years (AGE1; n = 87) and 53-65 years (AGE2; n = 61), and then subdivided according to being (or not) computer users (CUG; NCUG) during the workday. Homogeneous subgroups were randomly assigned (or not) to the daily intake of three pills of A/ω3 for three months. At baseline and at the end of follow-up, personalized interviews and ocular examination were done. Reflex tear samples were collected from the inferior meniscus and processed for a multiplexed particle-based flow cytometry assay to measure proinflammatory molecules. Statistics were performed using the SPSS 15.0 program. The OS pathology was clinically evident in the AGE1-CUG (33%) versus the AGE2-CUG (64%) of women. Significantly higher interleukins-1β and -6 tear levels were found in the AGE1 versus the AGE2 women employees (P = 0.006 and P = 0.001, resp.), as well as in the CUG versus the NCUG (P = 0.001 and P = 0.000, resp.). Supplementation with A/ω3 positively influenced the OS pathology as manifested by the amelioration of the clinical signs/symptoms related to computer uses. Strategies involving a safe environment and oral micronutrient supplements may be managed within eye-care standards in older women.

Citing Articles

Video display terminal use and dry eye: preventive measures and future perspectives.

Kamoy B, Magno M, Noland S, Moe M, Petrovski G, Vehof J Acta Ophthalmol. 2022; 100(7):723-739.

PMID: 35122403 PMC: 9790652. DOI: 10.1111/aos.15105.


Effects of intense pulsed light treatment on tear cytokines and clinical outcomes in meibomian gland dysfunction.

Li Q, Liu J, Liu C, Piao J, Yang W, An N PLoS One. 2021; 16(8):e0256533.

PMID: 34437596 PMC: 8389452. DOI: 10.1371/journal.pone.0256533.


Signature of Circulating Biomarkers in Recurrent Non-Infectious Anterior Uveitis. Immunomodulatory Effects of DHA-Triglyceride. A Pilot Study.

Pinazo-Duran M, Garcia-Medina J, Sanz-Gonzalez S, OConnor J, Casaroli-Marano R, Valero-Vello M Diagnostics (Basel). 2021; 11(4).

PMID: 33921773 PMC: 8072877. DOI: 10.3390/diagnostics11040724.


Treatment Satisfaction Among Patients Using Anti-Inflammatory Topical Medications for Dry Eye Disease.

White D, Zhao Y, Jayapalan H, Machiraju P, Periyasamy R, Ogundele A Clin Ophthalmol. 2020; 14:875-883.

PMID: 32256045 PMC: 7089601. DOI: 10.2147/OPTH.S233194.


Associations between the menstrual cycle, lifestyle factors and clinical assessment of the ocular surface: a prospective observational study.

Colorado L, Edwards K, Dinh L, Ha S, Liu D, Luu A BMC Womens Health. 2020; 20(1):23.

PMID: 32033559 PMC: 7006113. DOI: 10.1186/s12905-020-0894-z.


References
1.
Pinazo-Duran M, Gallego-Pinazo R, Garcia-Medina J, Zanon-Moreno V, Nucci C, Dolz-Marco R . Oxidative stress and its downstream signaling in aging eyes. Clin Interv Aging. 2014; 9:637-52. PMC: 3990383. DOI: 10.2147/CIA.S52662. View

2.
Gipson I, Spurr-Michaud S, Argueso P, Tisdale A, Ng T, Russo C . Mucin gene expression in immortalized human corneal-limbal and conjunctival epithelial cell lines. Invest Ophthalmol Vis Sci. 2003; 44(6):2496-506. DOI: 10.1167/iovs.02-0851. View

3.
Truong S, Cole N, Stapleton F, Golebiowski B . Sex hormones and the dry eye. Clin Exp Optom. 2014; 97(4):324-36. DOI: 10.1111/cxo.12147. View

4.
Barabino S, Chen Y, Chauhan S, Dana R . Ocular surface immunity: homeostatic mechanisms and their disruption in dry eye disease. Prog Retin Eye Res. 2012; 31(3):271-85. PMC: 3334398. DOI: 10.1016/j.preteyeres.2012.02.003. View

5.
Tsubota K, Kawashima M, Inaba T, Dogru M, Matsumoto Y, Ishida R . The antiaging approach for the treatment of dry eye. Cornea. 2012; 31 Suppl 1:S3-8. DOI: 10.1097/ICO.0b013e31826a05a8. View